Navigation Links
Leading Indian CRO 'Max Neeman International' Expands in Response to Positive Biosimilars Market in India
Date:12/5/2011

RESEARCH TRIANGLE PARK, N.C., Dec. 5, 2011 /PRNewswire/ -- A dedicated and experienced Max Neeman team has been set-up to conduct Biosimilar studies for evaluation and efficacy of products. The company expanded into this arena because India has demonstrated the greatest acceptance of Biosimilars reflected by over 50 biopharmaceutical brands getting marketing approval.  CEO, Dr. Ajoy Kumar firmly believes in a responsive, knowledge-based organization to meet client's needs.

(Logo: http://photos.prnewswire.com/prnh/20110105/CL25129LOGO)

The Indian Biosimilars market in 2008 was estimated to be worth approximately $200 million by Universal Consulting [India-based market research firm].  This is forecasted to reach $580 million by 2012 due to two key factors:  relative cost advantage of Biosimilars development versus competitors elsewhere and lower regulatory requirements for establishing bioequivalence [which also helps to keep development costs low].  Currently the manufacture and marketing of Biosimilars in India is governed by the Environment Protection Act of 1970 and the Drugs and Cosmetic Act. 

About Max Neeman International
Max Neeman International is a leading Indian CRO. Our specialty is that we offer services for the successful conduct of Phase II-IV clinical and device trials for small and mid-sized international and national Pharmaceutical, Biotechnology, Medical Device and Nutraceutical companies in compliance with ICH GCP standards. Operational since 2001, Max Neeman is also an ISO 9001:2008 & ISO 27001:2005 certified CRO for Monitoring, Site Management and Data Management Services. The company is presently active in 31 cities with 6 regional offices.   For more information, please contact Donald Swankie, Vice President Business Development at +1.919.424.3345 / donald.swankie@neeman-medical.com or visit www.neeman-medical.com.


'/>"/>
SOURCE Max Neeman International
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Boston Scientific Introduces Industry-Leading ICD and CRT-D Device Warranties
2. Leading Executives Once Again Meet at GDS International’s Next Generation Pharmaceutical Manufacturing Europe Summit to Discuss Key Objectives For The Industry
3. RealTime Medical to Feature Industry-Leading Cross-Platform, Automated Shared Workflow and Dynamic Workflow Assignment Software at RSNA 2011
4. Leading Chemical Weapons Preparedness Companies Announce Partnership to Deploy Break-through Diagnostic Test Internationally
5. PAREXEL Advances Early Phase CNS Research Capabilities With Leading Medical Imaging Technology
6. Qmed, the Leading Global MedTech Industry Resource Announces New Regulatory Tool to Streamline and Simplify the Regulatory and Product Development Process
7. United Spinal Secures Leading Public Policy and Durable Medical Equipment Specialist: Alex Bennewith is New Director of Government Relations
8. Leading Health Organizations and Patient Groups Call for 20 Percent Reduction in Fractures by 2020
9. Patients at Risk for Hepatitis B Are Not Adequately Screened Before Receiving Chemotherapy Leading to the Preventable Reactivation of Hepatitis B Infection
10. The Future of GPCRs in Drug Discovery: Novel technologies, leading companies, and opportunities for target expansion
11. Hypertronics Partners with UBM Canon, the Leading Global Medical Device Industry Source, to Co-Host Strategies for Avoiding Device Failure Seminar
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2017)... 18, 2017 EpiVax, Inc. ("EpiVax") ... and immune engineering, today announced a new ... (H7N9) vaccine. ... influenza and presents a challenge for traditional ... to be effective. Using state-of-the-art bioinformatics and molecular ...
(Date:9/12/2017)... NEW YORK , Sept. 12, 2017   EcoVadis , ... supply chains, has published the first annual edition of its Global CSR ... than 20,400 companies evaluated by EcoVadis, based on Scorecard Ratings that analyzed ... ... & Performance Index ...
(Date:9/12/2017)... , Sept. 12, 2017  ValGenesis Inc., the ... (VLMS), is pleased to announce the appointment of ... of its Board of Directors and Chairman of ... enables life science companies to manage their entire ... of paper in this process. Furthermore, ValGenesis VLMS ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... ... As health professionals work to improve their approach to healthcare, there is ... than filling out a survey; in many cases health professionals and patients are working ... and research on the importance of active engagement with patients and members of the ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... The American ... to become its next President and Chief Executive Officer, succeeding Dr. James C. Puffer ... Elect beginning July 1, 2018 until Dr. Puffer’s retirement at the end of 2018. ...
(Date:10/13/2017)... ... October 13, 2017 , ... PurhealthRX , a leading Health and Nutrition ... the Purzorb™process to full spectrum CBD oil will revolutionize the rapidly growing CBD market ... can be easily incorporated into liquid products, while reducing costs to end users. , ...
(Date:10/13/2017)... ... ... Lori R. Somekh, founder of the Law Office of Somekh & Associates ... special needs planning attorneys. “Membership in ElderCounsel helps our office remain up to date ... elder law attorneys nationwide,” said Somekh. , ElderCounsel was founded by ...
(Date:10/13/2017)... Calif. (PRWEB) , ... October 13, 2017 , ... Many ... dementia. However, many long-term care insurance companies have a waiver for care if the ... 90-day elimination period, when the family pays for care, is often waived, so the ...
Breaking Medicine News(10 mins):